All atropine Articles
-
597ClinicalObstacles with Compounded Low-Dose Atropine
sponsored content November 1, 2023 By Erin S. Tomiyama, OD, PhD, FAAO Most compounding pharmacies are small and do not have the...
-
553Research ReviewEffect of Topical Low-Dose Atropine on Binocular Vision and Accommodation
August 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Eye care professionals frequently prescribe topical low-dose atropine to slow myopic...
-
754Research ReviewCombination Therapy for Myopia Progression Control
July 5, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Most published myopia clinical trials study a single intervention versus control,...
-
1.1KResearch ReviewCHAMP Study Three-Year Results
June 15, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In a new study recently published in JAMA Ophthalmology, a novel preservative-free...
-
680Latest Myopia NewsFDA Accepts Vyluma’s New Drug Application for NVK002 Atropine
June 6, 2023 BRIDGEWATER, N.J. — The U.S. Food and Drug Administration (FDA) has accepted Vyluma’s new drug application (NDA) for its...
-
949Latest Myopia NewsMyopia Research Highlights from the ARVO 2023 Meeting
May 3, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE A gold mine for cutting-edge myopia research, the ARVO Meeting, held...
-
1.2KLatest Myopia NewsWSPOS Releases Myopia Consensus Statement 2023
DUBLIN – The World Society of Paediatric Ophthalmology and Strabismus has released its Myopia Consensus Statement 2023. The document details the interventions...
-
870Research ReviewPotentially Delaying the Onset of Myopia in Children
March 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Low concentration (0.01% to 0.05%) atropine effectively slows myopia progression in...
-
1.6KClinicalShould Atropine Be Prescribed for All Children Wearing OrthoK?
March 1, 2023 By Peter (Zhi) Chen, MD, PhD, Fudan University Eye and ENT Hospital, Shanghai, China Low-concentration atropine is needed only...
-
675Latest Myopia NewsHarrow’s Compounded Atropine Now Available Through ImprimisRx
February 15, 2023 NASHVILLE, Tenn. — U.S. pharmaceutical company Harrow has released its compounded, patent-pending formulas of low-dose atropine. Eye care professionals...
-
2.0KResearch Review
Combining OrthoK with 0.01% Atropine to Slow Axial Elongation
December 15, 2022 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Several clinical trials (Kinoshita et al., Kinoshita et al., Tan et...
-
2.1KClinicalEvidence-Based Treatment Algorithm Can Slow Myopia Progression
December 1, 2022 By Thomas Aller, OD, FBCLA There are advantages to being creative when controlling the progression of myopia in children...
-
2.1KClinicalVyluma CHAMP Pivotal Phase 3 Clinical Trial Q&A
sponsored content October 27, 2022 Vyluma aims to preserve the vision of a global population by providing meaningful and effective pharmaceutical ophthalmic...
-
1.2KResearch ReviewCompounding of Low-Concentration Atropine for Myopia Control
October 17, 2022 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FBCLA Topical low-concentration atropine is widely prescribed for myopia progression control in...
-
2.7KResearch ReviewMyopia Progression After Cessation of Low-Dose Atropine Treatment
October 3, 2022 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Many eye care professionals have expressed concern about rebound after children...
-
1.1KClinicalManaging Highly Myopic Children
October 3, 2022 By Krupa Philip, B.Optom, PhD, Senior Research Scientist at BHVI Depending on the strategy, there are some additional considerations...
-
2.2KResearch Review
Is 0.01% Atropine with Orthokeratology Better Than OrthoK Alone?
September 1, 2022 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The aim of the atropine combined with orthokeratology (AOK) study was...
-
1.3KInformed ConsentHow to Ease Parental Concerns When Presenting Off-Label Informed Consent
July 1, 2022 By Katherine Schuetz, OD We have an ever-growing armamentarium for myopia control; educate your patients and their parents about...
-
2.0KResearch ReviewPreventing Myopia Onset
June 1, 2022 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The International Myopia Institute’s white paper on Defining and Classifying Myopia...
-
4.3KBinocular VisionListening to Patients’ Needs Led Me to Myopia Management
April 15, 2022 By David Anderson, OD If I could say anything to a doctor who might ask me what to do...
-
1.4KResearch ReviewEfficacy and Safety of Various Atropine Concentrations for Myopia Control
April 1, 2022 By Geetha Sravani, PhD Candidate, Brien Holden Vision Institute Myopia prevalence is high in many Asian countries. To delay...
-
5.2KResearch ReviewEfficacy of Combined OrthoK and 0.01% Atropine in Myopia Control
March 1, 2022 By Linh Hoang, MD, MSc, and Huy Tran, MD, PhD Atropine and orthokeratology are effective in slowing myopia. Despite...
-
1.0KClinicalRecent Updates on Combination Treatments for Myopia Control
March 1, 2022 By Dr. Pavan K. Verkicharla and Mr. Swapnil Thakur It is important to note that there will be non-responders...
-
2.3KResearch ReviewThree-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression
January 17, 2022 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The aim of this clinical trial conducted in Hong Kong on...
-
7.9KClinicalOvernight Orthokeratology for Myopia: What Does the Evidence Say?
No one treatment is 100% effective at slowing the rate of myopia progression.
-
2.6KResearch ReviewSide Effects of Topical Atropine in Caucasian Myopic Children
April 15, 2021 By Dwight Akerman, OD, FAAO, FBCLA The LAMP study (low-concentration atropine for myopia progression) from Hong Kong addressed safety...
-
5.4KPharmaceutical InterventionsLow-Concentration Atropine for Myopia Progression (LAMP)
A summary of the LAMP Study results